MFH290 |
MFH290 : Covalent inhibitor of CDK12, CDK13
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK12 |
|
|
| CDK13 |
|
Covalent
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
MFH290 was tested on an extensive enzymatic CDKs panel which included CDKs 1–9, 12–14, and 16. The m ...
Selectivity Assessment Description:
CDK1: 1470 nM (Z’-Lyte); CDK2: 120 nM (Z’-Lyte); CDK3:
366 nM (LanthaScreen™ Eu); CDK4: >10000 nM (A ...
Potency Cellular
In Vitro
CDK12
Mode of Action: Covalent
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b01929
CDK13
Mode of Action: Covalent
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b01929
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.17 h
Systemic clearance:
102.03 mL/min/Kg
Cmax:
1312.89 ng/mL
Area Under the Curve::
162.22 h·ng/mL
Volume of Distribution at Steady-State:
730 mL/kg
DOI Reference: 10.1021/acs.jmedchem.9b01929
Dose: 5 mgKg
Route of delivery:
Intraperitoneal
Plasma half life:
0.15 h
Cmax:
885.05 ng/mL
Tmax:
0.08 h
Area Under the Curve::
393.63 h*ng/mL
Bioavailability:
49%
DOI Reference: 10.1021/acs.jmedchem.9b01929
Dose: 10 mg/Kg
Route of delivery:
Oral
Cmax:
556.46 ng/mL
Tmax:
0.25 h
Area Under the Curve::
412.44 h*ng/mL
Bioavailability:
25%
DOI Reference: 10.1021/acs.jmedchem.9b01929
Negative Control Compounds
Chemical Information
| Molecular Formula | C26H31N5O3S2 |
| SMILEs | C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1 |
| InChI | InChI=1S/C26H31N5O3S2/c1-5-21(32)29-18-10-8-17(9-11-18)24(33)31-12-6-7-19(15-31)30-25-28-14-23(36-25)35-16-22-27-13-20(34-22)26(2,3)4/h5,8-11,13-14,19H,1,6-7,12,15-16H2,2-4H3,(H,28,30)(H,29,32)/t19-/m1/s1 |
| Molecular weight | 525.19 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 67 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.